The Daily cover image

Why One Drug Company Held Back a Better Drug

The Daily

00:00

Gilead's Decision to Halt Development of New Drug to Maximize Profits

Gilead halted the development of a potentially better drug in order to maximize profits by keeping prices high. The documents suggest that the company didn't want to waste the precious patent and the newer version of the drug remained on the shelf for years while the older version continued to be sold.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app